21 CFR 640.53
§ 640.53 Testing the blood.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 640.53, § 640.53 Testing the blood, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/88494
- Permanent ID
ys:prov:88494@1- SHA-256
ab1317c3f601b67dcd98243cfcd78e8cde7dd3fe60e175940ff60295a97536ed
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Blood from which plasma is separated for the preparation of Cryoprecipitated AHF shall be tested as prescribed in § 610.40 of this chapter and § 640.5 (b) and (c).
(b) The tests shall be performed on a sample of blood collected at the time of collecting the source blood, and such sample container shall be labeled with the donor's number before the container is filled.
(c) Manufacturers of Cryoprecipitated AHF obtained from plasma collected by plasmapheresis shall have testing and record-keeping responsibilities equivalent to those prescribed in §§ 640.71 and 640.72.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.